Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - TELLING FRED
Last Updated 
10-Mar-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

TELLING FRED: Declared Holdings
Company/RelationshipReportedShares  Ownership
Cell Therapeutics, Inc.
Director
NasdaqCM:CTIC
(historical quotes, profile, SEC, other insiders)
7-Mar-14401,170  Direct
Oragenics, Inc. Common Stock
Director
NYSE MKT:OGEN
(historical quotes, profile, other insiders)
27-Nov-13229,174  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
7-Mar-14 72,095CTIC Sale at $3.73 - $3.8 per share.
(Proceeds of about $271,000)
30-Jan-14 146,000CTIC Acquisition (Non Open Market) at $0 per share.
27-Nov-13 38,397OGEN Acquisition (Non Open Market) at $0 per share.
18-Oct-13 33,185OGEN Acquisition (Non Open Market) at $0 per share.
26-Jun-13 86,957CTIC Acquisition (Non Open Market) at $0 per share.
30-May-13 64,798CTIC Sale at $1.22 - $1.26 per share.
(Proceeds of about $80,000)
21-Mar-13 28,093CTIC Disposition (Non Open Market) at $0 per share.
21-Mar-13 109,891CTIC Acquisition (Non Open Market) at $0 per share.
3-Dec-12 71,429CTIC Acquisition (Non Open Market) at $0 per share.
23-Oct-12 13,081OGEN Acquisition (Non Open Market) at $0 per share.
18-Sep-12 18,874CTIC Sale at $2.85 - $2.87 per share.
(Proceeds of about $54,000)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?